vs
PRECISION BIOSCIENCES INC（DTIL）与牛津地产（IIPR）财务数据对比。点击上方公司名可切换其他公司
牛津地产的季度营收约是PRECISION BIOSCIENCES INC的1.9倍（$66.7M vs $34.2M），PRECISION BIOSCIENCES INC净利率更高（58.9% vs 47.8%，领先11.1%），PRECISION BIOSCIENCES INC同比增速更快（5261.1% vs -13.1%），过去两年PRECISION BIOSCIENCES INC的营收复合增速更高（39.5% vs -6.0%）
精准生物科学公司是一家上市的美国临床阶段基因编辑企业，总部位于北卡罗来纳州达勒姆，成立于2006年。该公司依托自主研发的ARCUS基因组编辑平台，专注于开发体内和体外两类基因编辑疗法。
牛津地产是一家加拿大跨国企业，业务涵盖房地产投资、开发与物业管理。其投资组合包含写字楼、零售、工业、多户住宅、生命科学及酒店类资产。该公司1960年以私营企业形式创立，自2003年起成为安大略省市政雇员退休系统（OMERS）的全资子公司，总部设于多伦多，在纽约、伦敦、澳大利亚、新加坡及卢森堡均设有区域总部。
DTIL vs IIPR — 直观对比
营收规模更大
IIPR
是对方的1.9倍
$34.2M
营收增速更快
DTIL
高出5274.3%
-13.1%
净利率更高
DTIL
高出11.1%
47.8%
两年增速更快
DTIL
近两年复合增速
-6.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $34.2M | $66.7M |
| 净利润 | $20.1M | $31.8M |
| 毛利率 | — | — |
| 营业利润率 | 36.6% | 47.8% |
| 净利率 | 58.9% | 47.8% |
| 营收同比 | 5261.1% | -13.1% |
| 净利润同比 | 213.5% | -20.4% |
| 每股收益（稀释后） | $2.62 | $1.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DTILIIPR
| Q4 25 | $34.2M | $66.7M | ||
| Q3 25 | $13.0K | $64.7M | ||
| Q2 25 | $18.0K | $62.9M | ||
| Q1 25 | $29.0K | $71.7M | ||
| Q4 24 | $638.0K | $76.7M | ||
| Q3 24 | $576.0K | $76.5M | ||
| Q2 24 | $49.9M | $79.8M | ||
| Q1 24 | $17.6M | $75.5M |
净利润DTILIIPR
| Q4 25 | $20.1M | $31.8M | ||
| Q3 25 | $-21.8M | $29.3M | ||
| Q2 25 | $-23.5M | $26.0M | ||
| Q1 25 | $-20.6M | $31.1M | ||
| Q4 24 | — | $40.0M | ||
| Q3 24 | $-16.4M | $40.2M | ||
| Q2 24 | $32.7M | $42.0M | ||
| Q1 24 | $8.6M | $39.4M |
营业利润率DTILIIPR
| Q4 25 | 36.6% | 47.8% | ||
| Q3 25 | -158976.9% | 45.5% | ||
| Q2 25 | -121538.9% | 45.9% | ||
| Q1 25 | -76248.3% | 47.4% | ||
| Q4 24 | — | 54.7% | ||
| Q3 24 | -3693.6% | 54.8% | ||
| Q2 24 | 48.4% | 53.1% | ||
| Q1 24 | -23.8% | 55.7% |
净利率DTILIIPR
| Q4 25 | 58.9% | 47.8% | ||
| Q3 25 | -167476.9% | 45.3% | ||
| Q2 25 | -130666.7% | 41.4% | ||
| Q1 25 | -70913.8% | 43.3% | ||
| Q4 24 | — | 52.2% | ||
| Q3 24 | -2851.6% | 52.6% | ||
| Q2 24 | 65.6% | 52.6% | ||
| Q1 24 | 48.8% | 52.3% |
每股收益（稀释后）DTILIIPR
| Q4 25 | $2.62 | $1.07 | ||
| Q3 25 | $-1.84 | $0.97 | ||
| Q2 25 | $-2.13 | $0.86 | ||
| Q1 25 | $-2.21 | $1.03 | ||
| Q4 24 | — | $1.35 | ||
| Q3 24 | $-2.25 | $1.37 | ||
| Q2 24 | $4.67 | $1.44 | ||
| Q1 24 | $1.70 | $1.36 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $115.6M | $47.6M |
| 总债务越低越好 | — | $393.7M |
| 股东权益账面价值 | $92.2M | $1.8B |
| 总资产 | $154.4M | $2.4B |
| 负债/权益比越低杠杆越低 | — | 0.21× |
8季度趋势，按日历期对齐
现金及短期投资DTILIIPR
| Q4 25 | $115.6M | $47.6M | ||
| Q3 25 | $44.9M | $41.9M | ||
| Q2 25 | $62.2M | $104.9M | ||
| Q1 25 | $77.2M | $133.3M | ||
| Q4 24 | $86.3M | $151.2M | ||
| Q3 24 | $101.2M | $172.4M | ||
| Q2 24 | $123.6M | $160.9M | ||
| Q1 24 | $137.8M | $173.5M |
总债务DTILIIPR
| Q4 25 | — | $393.7M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益DTILIIPR
| Q4 25 | $92.2M | $1.8B | ||
| Q3 25 | $16.6M | $1.9B | ||
| Q2 25 | $34.1M | $1.9B | ||
| Q1 25 | $49.3M | $1.9B | ||
| Q4 24 | $56.4M | $1.9B | ||
| Q3 24 | $64.9M | $1.9B | ||
| Q2 24 | $74.7M | $1.9B | ||
| Q1 24 | $37.2M | $2.0B |
总资产DTILIIPR
| Q4 25 | $154.4M | $2.4B | ||
| Q3 25 | $93.5M | $2.3B | ||
| Q2 25 | $108.9M | $2.3B | ||
| Q1 25 | $124.4M | $2.4B | ||
| Q4 24 | $136.4M | $2.4B | ||
| Q3 24 | $153.3M | $2.4B | ||
| Q2 24 | $165.8M | $2.4B | ||
| Q1 24 | $184.7M | $2.4B |
负债/权益比DTILIIPR
| Q4 25 | — | 0.21× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-11.3M | $198.2M |
| 自由现金流经营现金流 - 资本支出 | $-11.3M | — |
| 自由现金流率自由现金流/营收 | -32.9% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | -0.56× | 6.22× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DTILIIPR
| Q4 25 | $-11.3M | $198.2M | ||
| Q3 25 | $-15.3M | $45.6M | ||
| Q2 25 | $-20.3M | $48.4M | ||
| Q1 25 | $-19.1M | $54.2M | ||
| Q4 24 | $-58.4M | $258.4M | ||
| Q3 24 | $-5.9M | $64.9M | ||
| Q2 24 | $-14.9M | $64.2M | ||
| Q1 24 | $-19.0M | $71.6M |
自由现金流DTILIIPR
| Q4 25 | $-11.3M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-20.3M | — | ||
| Q1 25 | $-19.1M | — | ||
| Q4 24 | $-58.7M | — | ||
| Q3 24 | $-6.0M | — | ||
| Q2 24 | $-14.9M | — | ||
| Q1 24 | $-19.1M | — |
自由现金流率DTILIIPR
| Q4 25 | -32.9% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -112627.8% | — | ||
| Q1 25 | -65917.2% | — | ||
| Q4 24 | -9199.8% | — | ||
| Q3 24 | -1033.2% | — | ||
| Q2 24 | -29.9% | — | ||
| Q1 24 | -108.4% | — |
资本支出强度DTILIIPR
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 11.1% | — | ||
| Q1 25 | 220.7% | — | ||
| Q4 24 | 39.2% | — | ||
| Q3 24 | 6.8% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.5% | — |
现金转化率DTILIIPR
| Q4 25 | -0.56× | 6.22× | ||
| Q3 25 | — | 1.56× | ||
| Q2 25 | — | 1.86× | ||
| Q1 25 | — | 1.75× | ||
| Q4 24 | — | 6.46× | ||
| Q3 24 | — | 1.61× | ||
| Q2 24 | -0.45× | 1.53× | ||
| Q1 24 | -2.21× | 1.82× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
